About Pike Therapeutics
Pike Therapeutics is a company based in Vancouver (Canada) founded in 2019 by Brad Miles.. Pike Therapeutics has raised $4.09 million across 3 funding rounds. The company has 49 employees as of December 19, 2024. Pike Therapeutics offers products and services including Continuous Transdermal Delivery Technology and Weekly CBD Delivery System. Pike Therapeutics operates in a competitive market with competitors including Hyasynth Bio, IGC Pharma, Hempsana, Soul Biotech and Nura Lyfe Sciences, among others.
- Headquarter Vancouver, Canada
- Employees 49 as on 19 Dec, 2024
- Founders Brad Miles
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pike Therapeutics Usa, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.09 M (USD)
in 3 rounds
-
Latest Funding Round
$2.99 M (USD), Series A
Dec 19, 2024
-
Investors
-
Employee Count
49
as on Dec 19, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pike Therapeutics
Pike Therapeutics offers a comprehensive portfolio of products and services, including Continuous Transdermal Delivery Technology and Weekly CBD Delivery System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables sustained release of drugs like CBD for enhanced efficacy.
Provides continuous CBD administration to improve patient treatment outcomes.
Unlock access to complete
Unlock access to complete
Leadership Team
3 people
Member Team
1 people
Finance and Accounting
1 people
Advisory Team
1 people
Unlock access to complete
Funding Insights of Pike Therapeutics
Pike Therapeutics has successfully raised a total of $4.09M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $2.99 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $3.0M
-
First Round
First Round
(31 Aug 2023)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2024 | Amount | Series A - Pike Therapeutics | Valuation |
investors |
|
| Dec, 2024 | Amount | Series A - Pike Therapeutics | Valuation |
investors |
|
| Aug, 2023 | Amount | Seed - Pike Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Pike Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Pike Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pike Therapeutics Comparisons
Competitors of Pike Therapeutics
Pike Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hyasynth Bio, IGC Pharma, Hempsana, Soul Biotech and Nura Lyfe Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of cannabinoid products intended to treat neurological disorders
|
|
| domain | founded_year | HQ Location |
Pharmaceutical products targeting neurological disorders like Alzheimer's are developed.
|
|
| domain | founded_year | HQ Location |
CBD oil processing solutions from hemp plants are provided.
|
|
| domain | founded_year | HQ Location |
Psychedelics, mushrooms, and cannabinoids are developed for mental health treatments.
|
|
| domain | founded_year | HQ Location |
Delivers comprehensive psychedelic and cannabinoid therapeutics for neurological disorders.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pike Therapeutics
Frequently Asked Questions about Pike Therapeutics
When was Pike Therapeutics founded?
Pike Therapeutics was founded in 2019 and raised its 1st funding round 4 years after it was founded.
Where is Pike Therapeutics located?
Pike Therapeutics is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Who is the current CEO of Pike Therapeutics?
Brad Miles is the current CEO of Pike Therapeutics. They have also founded this company.
Is Pike Therapeutics a funded company?
Pike Therapeutics is a funded company, having raised a total of $4.09M across 3 funding rounds to date. The company's 1st funding round was a Seed of $100K, raised on Aug 31, 2023.
How many employees does Pike Therapeutics have?
As of Dec 19, 2024, the latest employee count at Pike Therapeutics is 49.
What does Pike Therapeutics do?
Pike Therapeutics was founded in 2019 in Vancouver, Canada, as a developer in the biotechnology sector focused on psychedelic and cannabinoid-based drugs. Treatments are being created for conditions including chronic pain, inflammation, chemotherapy-induced nausea and vomiting, seizure disorders, and depression. These therapeutics are delivered transdermally to enable controlled and sustained drug release. Operations center on research and development of innovative delivery systems.
Who are the top competitors of Pike Therapeutics?
Pike Therapeutics's top competitors include IGC Pharma, Hyasynth Bio and Soul Biotech.
What products or services does Pike Therapeutics offer?
Pike Therapeutics offers Continuous Transdermal Delivery Technology and Weekly CBD Delivery System.